Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $164.2 million versus the consensus estimate of $164.57 million.

The company maintains its full-year 2019 adjusted diluted earnings per share outlook of $1.15 to $1.35. Additionally, the key planning assumptions that it provided on its year-end 2018 conference call, on February 26, remain unchanged.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.